Cargando…
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
BACKGROUND: Atrial fibrillation (AF) is a strong risk factor for Alzheimer’s disease (AD) independent of ischemic stroke. However, the clinicopathological impact of AF on the severity of AD has not been well elucidated. We aimed to investigate the clinical differences between dementia patients with...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838038/ https://www.ncbi.nlm.nih.gov/pubmed/36635728 http://dx.doi.org/10.1186/s13195-023-01165-1 |
_version_ | 1784869199856795648 |
---|---|
author | Nakase, Taizen Tatewaki, Yasuko Thyreau, Benjamin Odagiri, Hayato Tomita, Naoki Yamamoto, Shuzo Takano, Yumi Muranaka, Michiho Taki, Yasuyuki |
author_facet | Nakase, Taizen Tatewaki, Yasuko Thyreau, Benjamin Odagiri, Hayato Tomita, Naoki Yamamoto, Shuzo Takano, Yumi Muranaka, Michiho Taki, Yasuyuki |
author_sort | Nakase, Taizen |
collection | PubMed |
description | BACKGROUND: Atrial fibrillation (AF) is a strong risk factor for Alzheimer’s disease (AD) independent of ischemic stroke. However, the clinicopathological impact of AF on the severity of AD has not been well elucidated. We aimed to investigate the clinical differences between dementia patients with AF and those without AF by means of imaging data. METHODS: Following approval from the institutional ethics committee, patients with newly diagnosed AD or amnestic mild cognitive impairment (aMCI) were retrospectively screened (n = 170, 79.5 ± 7.4 years old). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Based on the MRI data, the cerebral volume, cerebral microbleeds (CMBs), periventricular white matter lesions (WMLs), and deep WMLs were evaluated. The regional cerebral blood flow (rCBF) was measured using (123)I-IMP SPECT. RESULTS: Of the patients, 14 (8.2%) and 156 (91.8%) had AF (AF group) and sinus rhythm (SR group), respectively. The AF group had significantly lower MMSE scores than the SR group (average [standard deviation (SD)]: 19.4 [4.4] and 22.0 [4.4], respectively; p = 0.0347). Cerebral volume and CMBs did not differ between the two groups. The periventricular WMLs, but not the deep WMLs, were significantly larger in the AF group than in the SR group (mean [SD] mL: 6.85 [3.78] and 4.37 [3.21], respectively; p = 0.0070). However, there was no significant difference in rCBF in the areas related to AD pathology between the two groups. CONCLUSION: AD and aMCI patients with AF showed worse cognitive decline along with larger periventricular WMLs compared to those with SR, although the reduction of rCBF was not different between patients with AF and SR. The white matter lesions may be a more important pathology than the impairment of cerebral blood flow in dementia patients with AF. A larger study is needed to confirm our findings in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01165-1. |
format | Online Article Text |
id | pubmed-9838038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98380382023-01-14 Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease Nakase, Taizen Tatewaki, Yasuko Thyreau, Benjamin Odagiri, Hayato Tomita, Naoki Yamamoto, Shuzo Takano, Yumi Muranaka, Michiho Taki, Yasuyuki Alzheimers Res Ther Research BACKGROUND: Atrial fibrillation (AF) is a strong risk factor for Alzheimer’s disease (AD) independent of ischemic stroke. However, the clinicopathological impact of AF on the severity of AD has not been well elucidated. We aimed to investigate the clinical differences between dementia patients with AF and those without AF by means of imaging data. METHODS: Following approval from the institutional ethics committee, patients with newly diagnosed AD or amnestic mild cognitive impairment (aMCI) were retrospectively screened (n = 170, 79.5 ± 7.4 years old). Cognitive function was assessed using the Mini-Mental State Examination (MMSE). Based on the MRI data, the cerebral volume, cerebral microbleeds (CMBs), periventricular white matter lesions (WMLs), and deep WMLs were evaluated. The regional cerebral blood flow (rCBF) was measured using (123)I-IMP SPECT. RESULTS: Of the patients, 14 (8.2%) and 156 (91.8%) had AF (AF group) and sinus rhythm (SR group), respectively. The AF group had significantly lower MMSE scores than the SR group (average [standard deviation (SD)]: 19.4 [4.4] and 22.0 [4.4], respectively; p = 0.0347). Cerebral volume and CMBs did not differ between the two groups. The periventricular WMLs, but not the deep WMLs, were significantly larger in the AF group than in the SR group (mean [SD] mL: 6.85 [3.78] and 4.37 [3.21], respectively; p = 0.0070). However, there was no significant difference in rCBF in the areas related to AD pathology between the two groups. CONCLUSION: AD and aMCI patients with AF showed worse cognitive decline along with larger periventricular WMLs compared to those with SR, although the reduction of rCBF was not different between patients with AF and SR. The white matter lesions may be a more important pathology than the impairment of cerebral blood flow in dementia patients with AF. A larger study is needed to confirm our findings in the future. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01165-1. BioMed Central 2023-01-13 /pmc/articles/PMC9838038/ /pubmed/36635728 http://dx.doi.org/10.1186/s13195-023-01165-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nakase, Taizen Tatewaki, Yasuko Thyreau, Benjamin Odagiri, Hayato Tomita, Naoki Yamamoto, Shuzo Takano, Yumi Muranaka, Michiho Taki, Yasuyuki Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease |
title | Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease |
title_full | Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease |
title_fullStr | Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease |
title_full_unstemmed | Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease |
title_short | Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease |
title_sort | impact of atrial fibrillation on the cognitive decline in alzheimer’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838038/ https://www.ncbi.nlm.nih.gov/pubmed/36635728 http://dx.doi.org/10.1186/s13195-023-01165-1 |
work_keys_str_mv | AT nakasetaizen impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT tatewakiyasuko impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT thyreaubenjamin impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT odagirihayato impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT tomitanaoki impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT yamamotoshuzo impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT takanoyumi impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT muranakamichiho impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease AT takiyasuyuki impactofatrialfibrillationonthecognitivedeclineinalzheimersdisease |